APA
Vincent J., Ramesh M. K., Ernest D., LaRosa S. P., Pachl J., Aikawa N., Hoste E., Levy H., Hirman J., Levi M., Daga M., Kutsogiannis D. J., Crowther M., Bernard G. R., Devriendt J., Puigserver J. V., Blanzaco D. U., Esmon C. T., Parrillo J. E., Guzzi L., Henderson S. J., Pothirat C., Mehta P., Fareed J., Talwar D., Tsuruta K., Gorelick K. J., Osawa Y. & Kaul I. (20131030). A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. : Critical care medicine.
Chicago
Vincent Jean-Louis, Ramesh Mayakonda K, Ernest David, LaRosa Steven P, Pachl Jan, Aikawa Naoki, Hoste Eric, Levy Howard, Hirman Joe, Levi Marcel, Daga Mradul, Kutsogiannis Demetrios J, Crowther Mark, Bernard Gordon R, Devriendt Jacques, Puigserver Joan Vidal, Blanzaco Daniel U, Esmon Charles T, Parrillo Joseph E, Guzzi Louis, Henderson Seton J, Pothirat Chaicharn, Mehta Parthiv, Fareed Jawed, Talwar Deepak, Tsuruta Kazuhisa, Gorelick Kenneth J, Osawa Yutaka and Kaul Inder. 20131030. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. : Critical care medicine.
Harvard
Vincent J., Ramesh M. K., Ernest D., LaRosa S. P., Pachl J., Aikawa N., Hoste E., Levy H., Hirman J., Levi M., Daga M., Kutsogiannis D. J., Crowther M., Bernard G. R., Devriendt J., Puigserver J. V., Blanzaco D. U., Esmon C. T., Parrillo J. E., Guzzi L., Henderson S. J., Pothirat C., Mehta P., Fareed J., Talwar D., Tsuruta K., Gorelick K. J., Osawa Y. and Kaul I. (20131030). A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. : Critical care medicine.
MLA
Vincent Jean-Louis, Ramesh Mayakonda K, Ernest David, LaRosa Steven P, Pachl Jan, Aikawa Naoki, Hoste Eric, Levy Howard, Hirman Joe, Levi Marcel, Daga Mradul, Kutsogiannis Demetrios J, Crowther Mark, Bernard Gordon R, Devriendt Jacques, Puigserver Joan Vidal, Blanzaco Daniel U, Esmon Charles T, Parrillo Joseph E, Guzzi Louis, Henderson Seton J, Pothirat Chaicharn, Mehta Parthiv, Fareed Jawed, Talwar Deepak, Tsuruta Kazuhisa, Gorelick Kenneth J, Osawa Yutaka and Kaul Inder. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. : Critical care medicine. 20131030.